Perger E, Taranto Montemurro L, Rosa D, Vicini S, et al. Reboxetine Plus Oxybutynin for OSA Treatment: A 1-Week, Randomized, Placebo-Controlled, Double-Blind Crossover Trial. Chest 2022;161:237-247.
PMID: 34543665